Please login to the form below
risperidone
This page shows the latest risperidone news and features for those working in and with pharma, biotech and healthcare.
J&J to FDA: there really is no asbestos in Baby Powder
as claims relating to damages that plaintiffs say stem from the company’s hip replacement and vaginal mesh products, and antipsychotic drug Risperdal (risperidone).
Latest news
-
Karuna’s shares spike on schizophrenia drug data
if it can be used in combination with existing atypical antipsychotic drugs that target dopamine and serotonin, such as aripiprazole, risperidone and olanzapine.
-
Litigation concerns threaten to overshadow solid quarter at J&J
risperidone), amongst others.
-
Brexit contributes to surge in generic drug prices
He says some medicines would be “particularly vulnerable" - highlighting a current shortage of pain and opioid addiction treatment Buprenorphine and antipsychotic Risperidone, arising in particular because there are no simple alternatives
-
Indivior push to diversify boosted by schizophrenia drug approval
The UK drugmaker has just won FDA approval for Perseris, a monthly injectable formulation of atypical antipsychotic risperidone, to treat schizophrenia.
-
Daily Brief: Italy in turmoil, Pharma attacks Europe's generics move and more
Its pipeline includes Risperidone Extended-Release Microspheres for Injection candidate (LY03004) for schizophrenia and bipolar disorder, and plans to launch in China and the US by the end of 2018, while
More from news
Approximately 1 fully matching, plus 34 partially matching documents found.
Latest Intelligence
-
20 for 2020 – Five pharma companies to watch
risperidone), as well as hip replacement and vaginal mesh products in its medical device business.
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Subscribe to our email news alerts
- Presenting Outstanding Outcomes from HCP Education in Multiple Myeloma at IMS in Athens
- Top 10 benefits of virtual advisory boards: Save Time and Resources
- NIHR launches new framework to highlight health progress outcomes
- Johns Hopkins and National Cancer Unit develop new genetic risk-scoring method for major diseases
- UKHSA secures UK-based vaccine deal for future influenza pandemics
- Novo Nordisk and Valo Health agree deal worth up to $3.3bn to develop cardiovascular treatments
No results were found
PMHub
Research Partnership
Research Partnership, an Inizio Advisory Company, is a world-leading custom and syndicated global insights partner for health and life science...
Latest intelligence
- The importance of accelerating clinical trial diversity
- Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...
- Digital Opinion Leaders: The Role of Influencers in Medical Communications
- There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...
- Creating Hope Though Action – World Suicide Prevention Day
- At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....
